Bafna Pharmaceuticals dividend history and dates
NSE: BAFNAPHBSE: 532989Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹451.95.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,048 Cr2,105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 134.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 10.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 8.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 4.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.39
- Volume, NSEVolume. Shares traded on the last trading day.
- 1,422
Next dividend, ex-date and record date
No dividend is announced. The last went ex on 19 Sep 2013: ₹0.60 a share.
All upcoming dividends ›Bafna Pharmaceuticals dividend calendar
Each payment in the month it went ex, as declared, ₹ a share at the time. Years running counted to the year to Mar 2026.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | In the year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | ₹0.60 | ₹0.60 |
Interim or final dividendSpecial dividendNone that month
Bafna Pharmaceuticals dividend history
Every payment with its ex-date and record date, the latest years open.
2013
- Sep19Thu
₹0.60Final
Ex-date 19 Sep 2013 · books closed to 30 Sep 2013
1.94%of the price
Grouped by the calendar year each went ex, so a year's total here can differ from the year it was paid for above. Of the price is the dividend as a share of the close on the session before its ex-date. A book closure is the run of days the company's register is frozen to settle who is paid; a record date is the one-day form of it.